查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375932

无引线起搏製造商市场规模、份额和趋势分析报告：按起搏室、最终用途、地区、细分市场趋势，2023-2030 年

Leadless Pacemakers Market Size, Share & Trends Analysis Report By Pacing Chamber (Single Chamber, Dual Chamber), By End-use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

无引线 S​​pacemaker 市场成长与趋势：

Grand View Research 的一份新报告显示，到 2030 年，全球无引线太空船市场预计将达到 17.4 亿美元。

预计2023年至2030年该市场将以15.7%的年复合成长率成长。市场的成长归因于技术进步、心臟病盛行率上升以及对微创手术的偏好。此外，世界人口高龄化正在推动对无引线起搏器的需求，因为心搏过缓在老化人口中更为常见。据克利夫兰诊所称，老年人口中约有 50 万人出现心搏过缓症状，这正在推动无引线起搏器产业的成长。

无线或无引线起搏器经常用于成年患者，但正如《循环》杂誌上发表的一项研究发现，对于心搏过缓的儿童患者来说，无线或无引线起搏器可以是一种安全有效的临时替代。这是可能的：这些是《心律不整和电生理学》杂誌上发表的一项研究的结果，美国心臟协会附属杂誌。这一市场开拓预计将成为市场成长的潜在驱动力。

此外，公司不断增加对无引线空间製造商的业务倡议正在支持行业成长。 2021年7月，微创科学公司就C轮资金筹措签署了最终协议。此次资金筹措成功吸引总投资1.5亿美元。此外，这笔资金筹措的主要目标之一是到 2027 年至 2028 年开发无引线太空船并将其商业化。

无引线起搏器市场报告亮点

  • 按地区划分，北美占据市场主导地位，2022 年收益占有率为 50.71%。这种增长是由于心臟病患者数量的增加、联邦法规机构产品核可的增加、技术进步以及手术可用性的增加。
  • 在起搏室方面，单室细分市场占据主导地位，2022年销售份额为67.40%。单腔无引线节律器适用于多种心搏过缓或心臟传导阻滞的患者。
  • 按最终用途划分，医院业占据市场主导地位，2022 年销售份额为 89.0%。这一份额归因于先进基础设施、研究合作和伙伴关係以及临床试验的可用性。

目录

第1章调查方法与范围

第2章执行摘要

第3章无引线心律调节器市场变数、趋势和范围

  • 市场体系展望
  • 市场趋势及展望
  • 市场动态
  • 营商环境分析

第4章无引线心律调节器市场：心律调节室业务分析

  • 无引线起搏器市场：起搏室运动和市场占有率分析，2022 年和 2030 年
  • 单室
  • 双室

第5章无引线太空船市场：最终用途业务分析

  • 无引线太空船市场：2022 年和 2030 年最终用途趋势和市场占有率分析
  • 医院
  • 门诊设施

第6章无引线太空船市场：区域业务分析

  • 区域市场简介
  • 2022 年按国家/地区分類的市场占有率分析
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第7章竞争形势

  • 公司分类
  • 策略规划
  • 公司简介/名单
    • Abbott
    • Medtronic
Product Code: GVR-4-68040-138-6

Leadless Pacemakers Market Growth & Trends:

The global leadless pacemakers market size is anticipated to reach USD 1.74 billion by 2030, based on a new report by Grand View Research, Inc.. The market is projected to grow at a CAGR of 15.7% from 2023 to 2030. The growth of the market is attributed to technological advancements, rising prevalence of heart diseases, and preference for minimally invasive procedures. Moreover, the growing aging population globally propels the demand for leadless pacemakers, as bradycardia is common in the geriatric population. According to the Cleveland Clinic, approximately half a million of the geriatric population show symptoms of bradycardia, thereby driving the growth in the leadless pacemakers industry.

Wireless or leadless pacemakers, frequently used in adult patients, have emerged as a potentially safe and efficient temporary alternative for children experiencing bradycardia, as revealed by research featured in Circulation: Arrhythmia and Electrophysiology, a peer-reviewed journal affiliated with the American Heart Association. This development is expected to be a potential driver for the growth of the market.

In addition, growing business initiatives by the companies for leadless pacemakers propels the industry growth. In July 2021, MicroPort Scientific Corporation concluded definitive agreements related to its Series C financing round. The financing has successfully garnered a total investment of USD 150 million. Moreover, one of the key objectives of this funding is to develop and commercialize its leadless pacemakers by 2027 - 2028.

Leadless Pacemakers Market Report Highlights:

  • In terms of region, North America dominated the market in 2022 with a revenue share of 50.71%. This growth can be attributed to the increasing number of heart patients, growing product approvals from federal regulatory bodies, technological advancements, and ease of accessibility of the procedure
  • In terms of pacing chamber, the single chamber segment dominated the market in 2022 with a revenue share of 67.40%. Single-chamber leadless pacemakers are suitable for a broader range of patients with bradycardia or heart block.
  • In terms of end-use, the hospitals segment dominated the market in 2022 with a revenue share of 89.0%. This share is attributed to the availability of advanced infrastructure, collaborations and partnerships, and clinical trials

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources & Third-Party Perspectives
    • 1.3.4. Primary Research
    • 1.3.5. Details of Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
    • 1.5.1. Volume Price Analysis
      • 1.5.1.1. Approach 1: Volume Price Analysis
  • 1.6. Data Validation & Publishing
  • 1.7. Global Market: CAGR Calculation
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Leadless Pacemakers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
      • 3.3.1.1. Rising prevalence of cardiovascular diseases
      • 3.3.1.2. Favorable reimbursement policies
      • 3.3.1.3. Growing adoption of leadless pacemaker instead of traditional pacemaker due to clinical safety.
    • 3.3.2. Market restraint analysis
      • 3.3.2.1. Limited manufacturers in the marketplace
  • 3.4. Business Environment Analysis
    • 3.4.1. SWOT Analysis; By Factor (Political & Legal, Economic and Technological)
    • 3.4.2. Porter's Five Forces Analysis
    • 3.4.3. COVID-19 Impact Analysis

Chapter 4. Leadless Pacemakers Market: Pacing Chamber Business Analysis

  • 4.1. Leadless Pacemakers Market: Pacing Chambers Movement & Market Share Analysis, 2022 & 2030
  • 4.2. Single Chamber
    • 4.2.1. Single Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.3. Dual Chamber
    • 4.3.1. Dual Chamber Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Leadless Pacemakers Market: End-use Business Analysis

  • 5.1. Leadless Pacemakers Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 5.2. Hospitals
    • 5.2.1. Hospitals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3. Outpatient Facilities
    • 5.3.1. Outpatient Facilities Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Leadless Pacemakers Market: Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. Market Share Analysis by Country, 2022
    • 6.2.1. North America
    • 6.2.2. Europe
    • 6.2.3. Asia Pacific
    • 6.2.4. Latin America
    • 6.2.5. MEA
  • 6.3. North America
    • 6.3.1. North America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. U.S. Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. Regulatory Framework
    • 6.3.3. Canada
      • 6.3.3.1. Canada Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Regulatory Framework
  • 6.4. Europe
    • 6.4.1. Europe Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Germany Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Regulatory Framework
    • 6.4.3. UK
      • 6.4.3.1. UK Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. Regulatory Framework
    • 6.4.4. France
      • 6.4.4.1. France Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. Regulatory Framework
    • 6.4.5. Italy
      • 6.4.5.1. Italy Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Regulatory Framework
    • 6.4.6. Spain
      • 6.4.6.1. Spain Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Regulatory Framework
    • 6.4.7. Denmark
      • 6.4.7.1. Denmark Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. Regulatory Framework
    • 6.4.8. Sweden
      • 6.4.8.1. Sweden Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.8.2. Key Country Dynamics
      • 6.4.8.3. Competitive Scenario
      • 6.4.8.4. Regulatory Framework
    • 6.4.9. Norway
      • 6.4.9.1. Norway Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.4.9.2. Key Country Dynamics
      • 6.4.9.3. Competitive Scenario
      • 6.4.9.4. Regulatory Framework
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Japan Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Regulatory Framework
    • 6.5.3. China
      • 6.5.3.1. China Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Regulatory Framework
    • 6.5.4. India
      • 6.5.4.1. India Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Regulatory Framework
    • 6.5.5. South Korea
      • 6.5.5.1. South Korea Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.5.2. Key Country Dynamics
      • 6.5.5.3. Competitive Scenario
      • 6.5.5.4. Regulatory Framework
    • 6.5.6. Australia
      • 6.5.6.1. Australia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.6.2. Key Country Dynamics
      • 6.5.6.3. Competitive Scenario
      • 6.5.6.4. Regulatory Framework
    • 6.5.7. Thailand
      • 6.5.7.1. Thailand Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.5.7.2. Key Country Dynamics
      • 6.5.7.3. Competitive Scenario
      • 6.5.7.4. Regulatory Framework
  • 6.6. Latin America
    • 6.6.1. Latin America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Brazil Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. Regulatory Framework
    • 6.6.3. Mexico
      • 6.6.3.1. Mexico Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Regulatory Framework
    • 6.6.4. Argentina
      • 6.6.4.1. Argentina Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. Regulatory Framework
  • 6.7. MEA
    • 6.7.1. MEA Leadless Pacemakers Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. South Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.2.2. Key Country Dynamics
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. Regulatory Framework
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Saudi Arabia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.3.2. Key Country Dynamics
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. Regulatory Framework
    • 6.7.4. UAE
      • 6.7.4.1. UAE Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.4.2. Key Country Dynamics
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Regulatory Framework
    • 6.7.5. Kuwait
      • 6.7.5.1. Kuwait Leadless Pacemakers Market, 2018 - 2030 (USD Million)
      • 6.7.5.2. Key Country Dynamics
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. Regulatory Framework

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Profiles/Listing
    • 7.3.1. Abbott
      • 7.3.1.1. Overview
      • 7.3.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.1.3. Product Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Medtronic
      • 7.3.2.1. Overview
      • 7.3.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.3.2.3. Product Benchmarking
      • 7.3.2.4. Strategic Initiatives

List of Tables

  • Table 1. List of Abbreviations
  • Table 2. List of Secondary Sources

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Leadless pacemakers market segmentation
  • Fig. 8 Market snapshot, 2022
  • Fig. 9 Market trends & outlook
  • Fig. 10 Market driver relevance analysis (current & future impact)
  • Fig. 11 Market restraint relevance analysis (current & future impact)
  • Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 13 Porter's five forces analysis
  • Fig. 14 Leadless Pacemakers Market: Pacing Chamber Outlook Key Takeaways
  • Fig. 15 Leadless Pacemakers Market: Pacing Chamber Movement Analysis
  • Fig. 16 Single Chamber Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Dual Chamber Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Leadless Pacemakers Market: End-use Outlook Key Takeaways
  • Fig. 19 Leadless Pacemakers Market: End-use Movement Analysis
  • Fig. 20 Hospitals Market Estimates and Forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Outpatient Facilities Market Estimates and Forecast Market, 2018 - 2030 (USD Million)
  • Fig. 22 Regional Marketplace: Key Takeaways
  • Fig. 23 Regional outlook, 2022 & 2030
  • Fig. 24 Global Leadless Pacemakers Market: Region Movement Analysis
  • Fig. 25 North America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 28 Europe Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 29 Germany Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 30 UK Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 31 France Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 32 Italy Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 33 Spain Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 35 Sweden Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 36 Norway Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 38 Japan Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 39 China Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 40 India Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 41 Australia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 42 South Korea Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 47 Argentina Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 48 Middle East and Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 49 South Africa Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 50 Saudi Arabia Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait Leadless Pacemakers Market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Leadless Pacemakers Market, 2018 - 2030 (USD Million)